Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

54.24
Delayed Data
As of 4:01pm ET
 -1.74 / -3.11%
Today’s Change
46.01
Today|||52-Week Range
76.80
-7.19%
Year-to-Date
With Cancer Rival's Immuno-oncology Flop, Bristol-Myers Looks Less Enticing for Suito...
4:13pm / TheStreet.com - Paid Partner Content
The Beatings Continue for Snapchat: Market Recon
6:46am / TheStreet.com - Paid Partner Content
AstraZeneca chief strikes defiant tone after drug disappointment
12:41pm / FT.com - Paid Partner Content
AVEO Pharmaceuticals (AVEO) Q2 Earnings: What's in Store?
Jul 26 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Beats on Q2 Earnings, Tweaks 2017 View
11:40am / Zacks.com - Paid Partner Content
Biotech Stocks Jul27 Q2 Earnings Roster: BMY, CELG & ALXN
Jul 26 / Zacks.com - Paid Partner Content
Gilead (GILD) Tops Q2 Earnings& Revenue Estimates, Stock Up
8:41am / Zacks.com - Paid Partner Content
Balasa Dinverno & Foltz Llc Buys iShares Edge MSCI USA Momentum Factor, General Elect...
Jul 26 / GuruFocus News - Paid Partner Content
Bristol-Myers (BMY) Q2 Earnings Beats Estimates
7:51am / Zacks.com - Paid Partner Content
Biogen Increases Revenue Guidance in 2nd Quarter
Jul 25 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close55.98
Today’s open53.30
Day’s range52.06 - 54.44
Volume21,644,326
Average volume (3 months)7,968,337
Market cap$92.2B
Dividend yield2.88%
Data as of 4:01pm ET, 07/27/2017

Growth & Valuation

Earnings growth (last year)+184.95%
Earnings growth (this year)+4.27%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+17.31%
P/E ratio18.8
Price/Sales5.05
Price/Book5.76

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+1.18+1.44%
ABTAbbott Laboratories-0.29-0.58%
AGNAllergan-1.99-0.78%
AZNAstraZeneca-5.06-14.91%
Data as of 4:02pm ET, 07/27/2017

Financials

Last reporting dateJuly 27, 2017
EPS forecast (this quarter)$0.73
Annual revenue (last year)$19.4B
Annual profit (last year)$4.5B
Net profit margin22.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Giovanni Caforio
CFO, EVP &
Head-Global Business Operations
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts